New free-access UOG Journal original study by by Prof. Nicolaides’ group.
The September issue of Ultrasound in Obstetrics & Gynecology is out now. This issue of the UOGJournal includes a Physician Alert in which the STRIDER Consortium address the recent suspension of the Dutch sildenafil trial, a Review of microRNA expression patterns in cardiac remodeling and pre-eclampsia, an Original Article on longitudinal growth assessment for prediction of adverse perinatal outcome in suspected small-for gestational-age fetuses, and a Case Series assessing fetal blood-gas values during fetoscopic myelomeningocele repair performed under carbon dioxide insufflation.
New, free-access UOG Journal editorial by ISUOG Ambassador to Egypt and North Africa Prof. Asma Khalil.
Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium - read the UOG Physician Alert here.
The July issue of Ultrasound in Obstetrics & Gynecology is out now. This issue has a special focus on fetal weight, with relevant articles on the accuracy of estimated fetal weight formulae, a new birth-weight reference chart that includes fetuses still in utero, and the screening and management of small-for-gestational-age fetuses.
Hear what the Founding Editor of Ultrasound in Obstetrics & Gynecology has to say about our outstanding new impact factor of 5.65. The UOG Journal is now ranked third out of 82 journals in obstetrics and gynecology.
Watch the new UOG Journal video abstract on a study by Tan and colleagues from Prof. Nicolaides’ group, showing that first-trimester screening for pre-eclampsia by maternal factors and biomarkers identifies a high proportion of cases of preterm SGA that can be prevented by the prophylactic use of aspirin.
ISUOG and the UOG team warmly welcome their new Editor-in-Chief, Anthony Odibo. After 8 years of service, Basky Thilaganathan has stepped down as Editor-in-Chief of Ultrasound in Obstetrics and Gynecology and Anthony Odibo has been appointed to take over the leadership role. About his new role, Anthony said: “I am honored by the opportunity and welcome the challenge”. We look forward to working with Tony to continue the Journal’s longstanding success.
The Ultrasound in Obstetrics and Gynecology (UOG) Journal impact factor has increased from 4.71 to 5.654!
The Ultrasound in Obstetrics and Gynecology (UOG) Journal impact factor has increased from 4.71 to 5.654, making UOG the second highest ranked obstetric journal! The White Journal includes a stimulating mixture of original research papers, randomised controlled trials and systematic reviews.
New research highlights a more accurate way to screen for pre-eclampsia in pregnant women than currently recommended methods. Published online in Ultrasound in Obstetrics & Gynecology, the study challenges the UK’s current guidelines on the management of hypertensive disorders during pregnancy.
A new Ultrasound in Obstetrics & Gynecology study provides evidence that pregnant women with hypertension can safely monitor their blood pressure at home instead of going into a hospital or clinic. This reduces the number of hospital visits without compromising their health or the health of their babies. The study included 108 women who were taught how to measure and record their blood pressure using a validated machine at home. A control group of 58 women was monitored in a clinic. There were no differences in adverse maternal, fetal, or neonatal outcomes.
A new analysis of published studies found a 50% increased risk of congenital heart defects in newborns when women become pregnant via in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) than through spontaneous conception.
A new analysis of published studies found an approximate 80% increased risk of spontaneous preterm birth (both before 37 and 34 weeks of gestation) when women become pregnant via in vitro fertilization (IVF) compared with through spontaneous conception.
Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: An updated meta-analysis of individual patient data
Majority of stillbirth cases remain unexplained, suggesting postmortem investigation needs to be refined
The EVERREST consortium aims to carry out the first trial of a novel maternal growth factor gene therapy for severe early-onset FGR.
Development and validation of a tool incorporating cervical length and quantitative fetal fibronectin to predict spontaneous preterm birth in asymptomatic high-risk women
Priority Setting Partnership publish 11 key research questions to reduce the number of stillbirths
Clinical implementation of routine Down-syndrome screening by NIPT
Critical trial identifies women most likely to benefit from vaginal mesh surgery